Home Amines 69739-16-8
69739-16-8,MFCD00864926
Catalog No.:AA01CCFK

69739-16-8 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, (6R,7R)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
97%(HPLC)
in stock  
$54.00   $38.00
- +
200mg
97%
in stock  
$97.00   $68.00
- +
1g
97%
in stock  
$182.00   $128.00
- +
5g
97%
in stock  
$490.00   $343.00
- +
25g
97%
in stock  
$1,531.00   $1,072.00
- +
100g
97%
in stock  
$4,168.00   $2,918.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA01CCFK
Chemical Name:
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, (6R,7R)-
CAS Number:
69739-16-8
Molecular Formula:
C20H20N6O7S4
Molecular Weight:
584.6688
MDL Number:
MFCD00864926
SMILES:
CO/N=C(/c1csc(n1)N)\C(=O)N[C@@H]1C(=O)N2[C@@H]1SCC(=C2C(=O)O)CSc1nc(c(s1)CC(=O)O)C
Properties
Computed Properties
 
Complexity:
1030  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
1  
Heavy Atom Count:
37  
Hydrogen Bond Acceptor Count:
15  
Hydrogen Bond Donor Count:
4  
Rotatable Bond Count:
10  
XLogP3:
0.2  

Literature

Title: BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.

Journal: Journal of pharmacokinetics and pharmacodynamics 20120201

Title: Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.

Journal: Bioorganic & medicinal chemistry 20110801

Title: Effects of cefodizime on chemokines of liver tissues in mice with immunological hepatic injury.

Journal: Chinese medical journal 20110301

Title: Microemulsion and mixed micelle for oral administration as new drug formulations for highly hydrophilic drugs.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100201

Title: Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.

Journal: Sexually transmitted infections 20090801

Title: Preparation, physicochemical characterization and biological evaluation of cefodizime metal ion complexes.

Journal: The Journal of pharmacy and pharmacology 20090601

Title: Inhibitory effects of Cefazolin and Cefodizime on the activity of mushroom tyrosinase.

Journal: Journal of enzyme inhibition and medicinal chemistry 20090201

Title: Population pharmacokinetics with a very small sample size.

Journal: Drug metabolism and drug interactions 20090101

Title: Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060601

Title: The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation.

Journal: International immunopharmacology 20060501

Title: Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.

Journal: International journal of antimicrobial agents 20060401

Title: Single dose of cefodizime completely eradicated multidrug-resistant strain of Neisseria gonorrhoeae in urethritis and uterine cervicitis.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060401

Title: Selective immediate hypersensitivity to cefodizime.

Journal: Allergy 20051201

Title: Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.

Journal: Journal of pharmaceutical sciences 20050701

Title: Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.

Journal: Journal of medicinal chemistry 20050630

Title: Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20050101

Title: [Pharyngeal gonococcal infections].

Journal: Nihon Jibiinkoka Gakkai kaiho 20040801

Title: Influence of enhancers on the absorption and on the pharmacokinetics of cefodizime using in-vitro and in-vivo models.

Journal: The Journal of pharmacy and pharmacology 20040401

Title: Immunomodulating effects of cefodizime on Klebsiella pneumoniae-stimulated neutrophils.

Journal: Immunobiology 20040101

Title: [Gonococcal infection].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20030201

Title: The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites.

Journal: Drug metabolism and pharmacokinetics 20020101

Title: Outbreak of acute renal failure due to cefodizime-vancomycin association in a heart surgery unit.

Journal: Intensive care medicine 20011101

Title: In vitro effect of amikacin, imipenem, cefodizime, IFNalpha-2a alone and combinations of antibiotics with IFNalpha-2a on polymorphonuclear leukocyte function in chronic hepatitis patients.

Journal: Chemotherapy 20010101

Title: Induction of tumor necrosis factor-alpha by cefodizime in U-937 cells.

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20010101

Title: Stability of cefodizime disodium in solid state.

Journal: Acta poloniae pharmaceutica 20010101

Title: Animal models as predictors of outcome of therapy with broad spectrum cephalosporins.

Journal: The Journal of antimicrobial chemotherapy 19920401

Title: [Acute toxicity study of cefodizime sodium].

Journal: The Journal of toxicological sciences 19880601

Title: [Six-month chronic intravenous toxicity study of cefodizime sodium in dogs].

Journal: The Journal of toxicological sciences 19880601

Title: [Nephrotoxicity of cefodizime sodium in rats--single and 14-day repeated intravenous administration].

Journal: The Journal of toxicological sciences 19880601

Title: [Six-month chronic subcutaneous toxicity study of cefodizime sodium in rats].

Journal: The Journal of toxicological sciences 19880601

Title: Barradell LB, et al. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1992 Nov;44(5):800-34.

Title: Hu T, et al. Probing the interaction of cefodizime with human serum albumin using multi-spectroscopic and molecular docking techniques. J Pharm Biomed Anal. 2015 Mar 25;107:325-32.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 69739-16-8
Tags:69739-16-8 Molecular Formula|69739-16-8 MDL|69739-16-8 SMILES|69739-16-8 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, (6R,7R)-